Cargando…

Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases

OBJECTIVES: Nucleic acid testing is the gold standard method for the diagnosis of coronavirus disease 2019 (COVID-19); however, large numbers of false-negative results have been reported. In this study, nucleic acid detection and antibody detection (IgG and IgM) were combined to improve the testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, H., Deng, S., Zhou, Z., Qiu, X., Jia, X., Li, Z., Wang, J., Duan, H., Tu, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The Royal Society for Public Health. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351380/
https://www.ncbi.nlm.nih.gov/pubmed/32731151
http://dx.doi.org/10.1016/j.puhe.2020.07.011
_version_ 1783557430440886272
author Zeng, H.
Deng, S.
Zhou, Z.
Qiu, X.
Jia, X.
Li, Z.
Wang, J.
Duan, H.
Tu, L.
Wang, J.
author_facet Zeng, H.
Deng, S.
Zhou, Z.
Qiu, X.
Jia, X.
Li, Z.
Wang, J.
Duan, H.
Tu, L.
Wang, J.
author_sort Zeng, H.
collection PubMed
description OBJECTIVES: Nucleic acid testing is the gold standard method for the diagnosis of coronavirus disease 2019 (COVID-19); however, large numbers of false-negative results have been reported. In this study, nucleic acid detection and antibody detection (IgG and IgM) were combined to improve the testing accuracy of patients with suspected COVID-19. STUDY DESIGN: The positive rate of nucleic acid detection and antibody detection (IgG and IgM) were compared in suspected COVID-19 patients. METHODS: A total of 71 patients with suspected COVID-19 were selected to participate in this study, which included a retrospective analysis of clinical features, imaging examination, laboratory biochemical examination and nucleic acid detection and specific antibody (IgM and IgG) detection. RESULTS: The majority of participants with suspected COVID-19 presented with fever (67.61%) and cough (54.93%), and the imaging results showed multiple small patches and ground-glass opacity in both lungs, with less common infiltration and consolidation opacity (23.94%). Routine blood tests were mostly normal (69.01%), although only a few patients had lymphopenia (4.23%) or leucopenia (12.68%). There was no statistical difference in the double-positive rate between nucleic acid detection (46.48%) and specific antibody (IgG and IgM) detection (42.25%) (P = 0.612), both of which were also poorly consistent with each other (kappa = 0.231). The positive rate of combined nucleic acid detection and antibody detection (63.38%) was significantly increased, compared with that of nucleic acid detection (46.48%) and that of specific antibody (IgG and IgM) detection (42.25%), and the differences were statistically significant (P = 0.043 and P = 0.012, respectively). CONCLUSIONS: Nucleic acid detection and specific antibody (IgG and IgM) detection had similar positive rates, and their combination could improve the positive rate of COVID-19 detection, which is of great significance for diagnosis and epidemic control.
format Online
Article
Text
id pubmed-7351380
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
record_format MEDLINE/PubMed
spelling pubmed-73513802020-07-13 Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases Zeng, H. Deng, S. Zhou, Z. Qiu, X. Jia, X. Li, Z. Wang, J. Duan, H. Tu, L. Wang, J. Public Health Original Research OBJECTIVES: Nucleic acid testing is the gold standard method for the diagnosis of coronavirus disease 2019 (COVID-19); however, large numbers of false-negative results have been reported. In this study, nucleic acid detection and antibody detection (IgG and IgM) were combined to improve the testing accuracy of patients with suspected COVID-19. STUDY DESIGN: The positive rate of nucleic acid detection and antibody detection (IgG and IgM) were compared in suspected COVID-19 patients. METHODS: A total of 71 patients with suspected COVID-19 were selected to participate in this study, which included a retrospective analysis of clinical features, imaging examination, laboratory biochemical examination and nucleic acid detection and specific antibody (IgM and IgG) detection. RESULTS: The majority of participants with suspected COVID-19 presented with fever (67.61%) and cough (54.93%), and the imaging results showed multiple small patches and ground-glass opacity in both lungs, with less common infiltration and consolidation opacity (23.94%). Routine blood tests were mostly normal (69.01%), although only a few patients had lymphopenia (4.23%) or leucopenia (12.68%). There was no statistical difference in the double-positive rate between nucleic acid detection (46.48%) and specific antibody (IgG and IgM) detection (42.25%) (P = 0.612), both of which were also poorly consistent with each other (kappa = 0.231). The positive rate of combined nucleic acid detection and antibody detection (63.38%) was significantly increased, compared with that of nucleic acid detection (46.48%) and that of specific antibody (IgG and IgM) detection (42.25%), and the differences were statistically significant (P = 0.043 and P = 0.012, respectively). CONCLUSIONS: Nucleic acid detection and specific antibody (IgG and IgM) detection had similar positive rates, and their combination could improve the positive rate of COVID-19 detection, which is of great significance for diagnosis and epidemic control. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. 2020-09 2020-07-10 /pmc/articles/PMC7351380/ /pubmed/32731151 http://dx.doi.org/10.1016/j.puhe.2020.07.011 Text en © 2020 Published by Elsevier Ltd on behalf of The Royal Society for Public Health. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research
Zeng, H.
Deng, S.
Zhou, Z.
Qiu, X.
Jia, X.
Li, Z.
Wang, J.
Duan, H.
Tu, L.
Wang, J.
Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title_full Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title_fullStr Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title_full_unstemmed Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title_short Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases
title_sort diagnostic value of combined nucleic acid and antibody detection in suspected covid-19 cases
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351380/
https://www.ncbi.nlm.nih.gov/pubmed/32731151
http://dx.doi.org/10.1016/j.puhe.2020.07.011
work_keys_str_mv AT zengh diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT dengs diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT zhouz diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT qiux diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT jiax diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT liz diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT wangj diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT duanh diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT tul diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases
AT wangj diagnosticvalueofcombinednucleicacidandantibodydetectioninsuspectedcovid19cases